U.S. Markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
239.79-1.75 (-0.72%)
At close: 4:00PM EDT
240.82 +1.03 (0.43%)
After hours: 07:36PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close241.54
Bid238.50 x 900
Ask240.50 x 1200
Day's Range238.37 - 242.48
52 Week Range210.28 - 276.69
Avg. Volume2,454,823
Market Cap137.772B
Beta (5Y Monthly)0.71
PE Ratio (TTM)19.86
EPS (TTM)12.07
Earnings DateOct 26, 2021 - Nov 01, 2021
Forward Dividend & Yield7.04 (2.95%)
Ex-Dividend DateMay 14, 2021
1y Target Est254.96
  • Investopedia

    Amgen (AMGN) Option Traders Unenthusiastic Into Earnings

    Trading volumes indicate that traders have been selling calls and buying puts in anticipation of an unfavorable earnings report.

  • Drug/Biotech Stock Q2 Earnings on Aug 3: LLY, AMGN & More

    Drug/Biotech Stock Q2 Earnings on Aug 3: LLY, AMGN & More

    Let us take a look at four drug/biotech companies, LLY, AMGN, INCY and ALNY, which are gearing up for their earnings release.

  • Carter Worth And Mike Khouw's Amgen Trade

    Carter Worth And Mike Khouw's Amgen Trade

    Carter Worth and Mike Khouw teamed up on CNBC's "Options Action" to give the viewers a bearish trade in Amgen, Inc. (NASDAQ: AMGN) ahead of earnings. Worth analyzed the stock from a technical standpoint and he concluded the stock doesn't act well. In the last week, Health Care Select Sector SPDR Fund (NYSE: XLV) gained 0.7%, which was enough to beat the market. Amgen, on the other hand, dropped 2.2% and underperformed both the sector and the market. Its monthly performance was not good either. I